0
Articles |

Effects of Long-term Oxygen Therapy on Pulmonary Hemodynamics in COPD Patients : A 6-Year Prospective Study

Jan Zieliński; Mirosław Tobiasz; Iwona Hawryłkiewicz; Paweł Śliwiński; Grzegorz Pałasiewicz
Author and Funding Information

From the Department of Respiratory Medicine, Institute of Tuberculosis and Lung Diseases, Warsaw, Poland


1998 by the American College of Chest Physicians


Chest. 1998;113(1):65-70. doi:10.1378/chest.113.1.65
Text Size: A A A
Published online

Abstract

Objective: To investigate effects of 6 years of domiciliary oxygen therapy on pulmonary hemodynamics in a large group of COPD patients.

Design: Prospective longitudinal study with serial measurements.

Setting: Research institute of pulmonary diseases.

Patients: Ninety-five patients (72 men, 23 women), mean age 58±9 years, had COPD but were free of any other serious disease. Functional characteristics at entry, mean±SD, were as follows: FVC=2.24±0.51 L; FEV1=0.84±0.31 L; PaO2=55±6 mm Hg; PaCO2=48±9 mm Hg; mean pulmonary arterial pressure (PAP)=28±11 mm Hg; and pulmonary vascular resistance (PVR)=353±172 dyne·s·cm−5.

Methods: Pulmonary hemodynamics were investigated using Swan-Ganz thermodilution catheters. After initial assessment, all patients were started on a regimen of long-term oxygen therapy (LTOT). Follow-up consisted of medical examination, spirometry, and arterial blood gas analysis every 3 months. Pulmonary artery catheterization was repeated every 2 years.

Results: Seventy-three subjects survived 2 years of LTOT. In 39 subjects catheterized after 2 years, PAP fell from 25±8 to 23±6 mm Hg (not significant [NS]). From 31 patients who completed 4 years of LTOT, hemodynamic data were obtained in 20. In these 20 patients, PAP averaged 24±7 mm Hg at entry, and 23±5 and 26±6 mm Hg after 2 and 4 years, respectively (NS). In 12 patients who completed 6 years of LTOT, PAP was 25±7 at entry, and 21±4, 26±7, and 26±6 mm Hg at 2, 4, and 6 years, respectively (p<0.01 for 2 vs 6 years). PVR was 313±159 dyne·s·cm−5 at entry, and 268±110, 344±82, and 332±205 dyne·s·cm−5 at 2, 4, and 6 years, respectively (NS). During 6 years of follow-up, PaO2 decreased from 61±3 to 46±9 mm Hg (p<0.001) and PaCO2 increased from 44±13 to 49±9 mm Hg (p<0.01).

Conclusion: LTOT for 14 to 15 h/d resulted in a small reduction in pulmonary hypertension after the first 2 years followed by a return to initial values and subsequent stabilization of PAP over 6 years. The long-term stabilization of pulmonary hypertension occurred despite progression of the airflow limitation and of hypoxemia.


Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543